Recent advance in prognostic factors in patients with interventional embolization of intracranial ruptured aneurysms

doi:10.3877/cma.j.issn.2095-123X.2019.06.012

Abstract

Abstract:

Patients with intracranial ruptured aneurysm have the characteristics of high mortality and high disability rate. Interventional therapy has gradually become the first choice of treatment. Any improper handling link in the treatment process will affect the prognosis of patients. Currently, there are few systematic reviews in this regard. Therefore, this paper summarized the main factors affecting the prognosis of patients with interventional embolization of intracranial ruptured aneurysm, in order to provide a reference for clinical treatment, so as to reduce the mortality and disability rate and improve the prognosis of patients.

Key words: Intracranial ruptured aneurysm, Interventional embolization, Cerebral vasospasm, Delayed cerebral ischemia, Cerebral infarction

Chuanyu Li, Haineng Huang, Qisheng Luo, Weiwei Xu, Xiangyu Wang. Recent advance in prognostic factors in patients with interventional embolization of intracranial ruptured aneurysms[J]. Chinese Journal of Brain Diseases and Rehabilitation(Electronic Edition), 2019, 09(06): 371-374.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhnkjbykfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-123X.2019.06.012

https://zhnkjbykfzz.cma-cmc.com.cn/EN/Y2019/V09/I06/371

References 44

[1]	Okazaki T, Kuroda Y. Aneurysmal subarachnoid hemorrhage: intensive care for improving neurological outcome[J]. J Intensive Care, 2018, 6: 28.
[2]	范存刚,孙澎,张庆俊. 2012年AHA/ASA《动脉瘤性蛛网膜下腔出血的诊疗指南》解读[J].中华神经医学杂志, 2013, 12(6): 541-544.
[3]	van Donkelaar CE, Bakker NA, Birks J, et al. Prediction of outcome after aneurysmal subarachnoid hemorrhage[J]. Stroke, 2019, 50(4): 837-844.
[4]	Nieuwkamp DJ, Setz LE, Algra A, et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis[J]. Lancet Neurol, 2009, 8(7): 635-642.
[5]	le Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage[J]. Neurosurg Clin N Am, 2010, 21(2): 235-246.
[6]	Greving JP, Wermer MJ, Brown RD Jr, et al. Development of the phases score for prediction of risk of rupture of intracranial aneurysms: a pooled analysis of six prospective cohort studies[J]. Lancet Neurol, 2014, 13(1): 59-66.
[7]	钟鸣,赵兵.全国高分级动脉瘤性蛛网膜下腔出血诊疗策略高峰论坛纪要[J].中国脑血管病杂志, 2010, 7(2): 112.
[8]	吴雪海,胡锦,高亮,等.重症神经外科患者的颅内压监测指征与规范化治疗[J].中华急诊医学杂志, 2013, 22(12): 1321-1323.
[9]	黄清海,刘建民.倡导循证,更新观念,强化资质,推动颅内动脉瘤血管内介入治疗规范化发展——记《颅内动脉瘤血管内介入治疗中国专家共识(2013)》发布[J].中华医学杂志, 2013, 93(39): 3089-3090.
[10]	Molyneux A, Kerr R, Stratton I, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial[J]. J Stroke Cerebrovasc Dis, 2002, 11(6): 304-314.
[11]	Darsaut TE, Raymond J. Barrow ruptured aneurysm trial: 3-year results[J]. J Neurosurg, 2013, 119(6): 1642-1644.
[12]	Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: Proposal of a multidisciplinary research group[J]. Stroke, 2010, 41(10): 2391-2395.
[13]	Otite F, Mink S, Tan CO, et al. Impaired cerebral autoregulation is associated with vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage[J]. Stroke, 2014, 45(3): 677-682.
[14]	Calviere L, Nasr N, Arnaud C, et al. Prediction of delayed cerebral ischemia after subarachnoid hemorrhage using cerebral blood flow velocities and cerebral autoregulation assessment[J]. Neurocrit Care, 2015, 23(2): 253-258.
[15]	中华医学会神经外科学分会.脑血管痉挛防治神经外科专家共识[J].中华医学杂志, 2008, 88(31): 2161-2165.
[16]	李传玉,黄华东,黄海能.改良腰大池持续外引流在治疗动脉瘤栓塞术后脑积水的应用[J].中华神经创伤外科电子杂志, 2019, 5(3): 189-191.
[17]	Liu GJ, Luo J, Zhang LP, et al. Meta-analysis of the effectiveness and safety of prophylactic use of nimodipine in patients with an aneurysmal subarachnoid haemorrhage[J]. CNS Neurol Disord Drug Targets, 2011, 10(7): 834-844.
[18]	张永超,郑鑫辉,张振,等. "3H"疗法在动脉瘤性蛛网膜下腔出血临床应用分析[J].中华神经外科疾病研究杂志, 2015, 14(4): 363-364.
[19]	Tagami T, Kuwamoto K, Watanabe A, et al. Effect of triple-H prophylaxis on global end-diastolic volume and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2014, 21(3): 462-469.
[20]	Aburto-Murrieta Y, Marquez-Romero JM, Bonifacio-Delgadillo D, et al. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage[J]. Vasc Endovascular Surg, 2012, 46(6): 460-465.
[21]	Rahme R, Jimenez L, Pyne-Geithman GJ, et al. Endovascular management of posthemorrhagic cerebral vasospasm: indications, technical nuances, and results[J]. Acta Neurochir Suppl, 2013, 115: 107-112.
[22]	Nakamura T, Matsui T, Hosono A, et al. Beneficial effect of selective intra-arterial infusion of Fasudil hydrochloride as a treatment of symptomatic vasospasm following SAH[J]. Acta Neurochir Suppl, 2013, 115: 81-85.
[23]	李传玉,黄海能,黄华东,等.早期与延迟介入治疗对颅内破裂动脉瘤患者的疗效和DCI发生率的差异[J].中华脑科疾病与康复杂志(电子版), 2019, 9(1): 30-35.
[24]	Tao C, Fan C, Hu X, et al. The effect of fenestration of the lamina terminalis on the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage (FISH): study protocol for a randomized controlled trial[J]. Medicine (Baltimore), 2016, 95(52): e5727.
[25]	Lim YC, Shim YS, Oh SY, et al. External ventricular drainage before endovascular treatment in patients with aneurysmal subarachnoid hemorrhage in acute period: its relation to hemorrhagic complications[J]. Neurointervention, 2019, 14(1): 35-42.
[26]	Cagnazzo F, Gambacciani C, Morganti R, et al. Aneurysm rebleeding after placement of external ventricular drainage: a systematic review and meta-analysis[J]. Acta Neurochir (Wien), 2017, 159(4): 695-704.
[27]	周建新,赵继宗.进一步规范抗菌药物在神经外科医院感染中的应用——解读《神经外科医院感染抗菌药物应用专家共识》[J].中华医学杂志, 2013, 93(5): 321.
[28]	Alcalá-Cerra G, Paternina-Caicedo á, Díaz-Becerra C, et al. External lumbar cerebrospinal fluid drainage in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of controlled trials[J]. Neurologia, 2016, 31(7): 431-444.
[29]	Park S, Yang N, Seo E. The effectiveness of lumbar cerebrospinal fluid drainage to reduce the cerebral vasospasm after surgical clipping for aneurysmal subarachnoid hemorrhage[J]. J Korean Neurosurg Soc, 2015, 57(3): 167-173.
[30]	Hellingman CA, van den Bergh WM, Beijer IS, et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage[J]. Stroke, 2007, 38(1): 96-99.
[31]	李传玉,黄海能,黄华东,等.腰大池持续引流治疗aSAH后发生分流依赖性脑积水的影响因素分析[J].中华脑科疾病与康复杂志(电子版), 2019, 9(1): 15-19.
[32]	Nathan SK, Brahme IS, Kashkoush AI, et al. Risk factors for in-hospital seizures and new-onset epilepsy in coil embolization of aneurysmal subarachnoid hemorrhage[J]. World Neurosurg, 2018, 115: e523-e531.
[33]	Yang H, Rajah G, Guo A, et al. Pathogenesis of epileptic seizures and epilepsy after stroke[J]. Neurol Res, 2018, 40(6): 426-432.
[34]	Hoh BL, Nathoo S, Chi YY, et al. Incidence of seizures or epilepsy after clipping or coiling of ruptured and unruptured cerebral aneurysms in the nationwide inpatient sample database: 2002-2007[J]. Neurosurgery, 2011, 69(3): 644-650; discussion 650.
[35]	Gilmore E, Choi HA, Hirsch LJ, et al. Seizures and CNS hemorrhage: spontaneous intracerebral and aneurysmal subarachnoid hemorrhage[J]. Neurologist, 2010, 16(3): 165-175.
[36]	Human T, Diringer MN, Allen M, et al. A randomized trial of brief versus extended seizure prophylaxis after aneurysmal subarachnoid hemorrhage[J]. Neurocrit Care, 2018, 28(2): 169-174.
[37]	Sykes L, Wood E, Kwan J. Antiepileptic drugs for the primary and secondary prevention of seizures after stroke[J]. Cochrane Database Syst Rev, 2010, 1: CD005398.
[38]	Naidech AM, Kreiter KT, Janjua N, et al. Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage[J]. Stroke, 2005, 36(3): 583-587.
[39]	Mahaney KB, Brown RD Jr, Torner JC, et al. International study of unruptured intracranial aneurysms. Response[J]. J Neurosurg, 2014, 121(5): 1022-1023.
[40]	Kang H, Peng T, Qian Z, et al. Impact of hypertension and smoking on the rupture of intracranial aneurysms and their joint effect[J]. Neurol Neurochir Pol, 2015, 49(2): 121-125.
[41]	Wiebers DO, Whisnant JP, Huston J, et al. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment[J]. Lancet, 2003, 362(9378): 103-110.
[42]	Mocco J, Brown RD Jr, Torner JC, et al. Aneurysm morphology and prediction of rupture: an international study of unruptured intracranial aneurysms analysis[J]. Neurosurgery, 2018, 82(4): 491-496.
[43]	Wang HF, Wang DM. Letter: aneurysm morphology and prediction of rupture: an international study of unruptured international aneurysms analysis[J]. Neurosurgery, 2019, 84(5): E287.
[44]	Xiang J, Tutino VM, Snyder KV, et al. CFD: computational fluid dynamics or confounding factor dissemination? The role of hemodynamics in intracranial aneurysm rupture risk assessment[J]. AJNR Am J Neuroradiol, 2014, 35(10): 1849-1857.

Please choose a citation manager

Content to export